CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...

Prostate cancer is the most common cancer in men and is second most common cause of cancer deaths. Importantly, the annual rates of prostate cancer incidence continue to rise. This session will delve ...

In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate ...

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...

Men diagnosed with metastatic hormone-sensitive prostate cancer who carry a specific tumor deficiency now have a targeted ...

Human tissue is intricate, complex and, of course, three dimensional. But the thin slices of tissue that pathologists most often use to diagnose disease are two dimensional, offering only a limited ...

The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...

Significant progress in localized prostate cancer has been made, including improved and early detection, targeted biopsy, grading, disease prognostication, and outcome prediction, using imaging and ...

According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing ...

Pathologic concordance between prostate biopsy and radical prostatectomy improves with use of a novel robotic-assisted transperineal fusion biopsy platform. Optimization of risk stratification at ...

Suffering from prostate cancer or benign prostatic hyperplasia (BPH) is not the end of a relationship. Technology and sexologists offer solutions to maintain erections and orgasms, even if ejaculation ...